• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

消化不良症状的强度和变异性。

The intensity and variability of symptoms in dyspepsia.

作者信息

Johannessen T, Petersen H, Kristensen P, Kleveland P M, Dybdahl J, Sandvik A K, Brenna E, Waldum H

机构信息

Department of Community Medicine and General Practice, University of Trondheim, Norway.

出版信息

Scand J Prim Health Care. 1993 Mar;11(1):50-5. doi: 10.3109/02813439308994902.

DOI:10.3109/02813439308994902
PMID:8484080
Abstract

During the waiting time for upper gastrointestinal endoscopy 165 patients with dyspepsia completed a questionnaire and a diary for daily measurements of the symptoms pain, heartburn, and global complaints. 23 patients (14%) had peptic ulcer disease (PUD), 18 oesophagitis (11%), and the rest were labelled nonulcer dyspepsia (NUD). NUD was further subdivided into ulcer-like, reflux-like, dysmotility, and essential NUD by means of predefined symptom profiles. 39 (24%) patients were on H2 receptor antagonist treatment. In general, the intensity of the daily symptoms was rather low, and except for a higher rating of heartburn in oesophagitis, there were no significant differences between PUD, oesophagitis, and NUD--treated or untreated. NUD patients with reflux-like dyspepsia had significantly more heartburn than the group with essential NUD; otherwise there were no differences between the subgroups of NUD. The individual daily ratings for abdominal pain, heartburn, and global symptoms varied by an average standard deviation of 64%, 97% and 47% of the mean values, respectively, and were independent of treatment or diagnoses. There was an approximately 40% probability that two successive days had different levels of symptoms. Only 10% of the patients showed stable symptoms, and the patients were completely symptom-free for 20% of the observation period. Symptoms in dyspepsia patients disclosed low intensity and high variability in this study. Such factors may be important sources of bias in clinical trials.

摘要

在上消化道内镜检查的等待期间,165例消化不良患者完成了一份问卷和一本日记,用于每日测量疼痛、烧心及整体不适等症状。23例患者(14%)患有消化性溃疡病(PUD),18例患有食管炎(11%),其余患者被诊断为非溃疡性消化不良(NUD)。NUD根据预先定义的症状特征进一步细分为溃疡样、反流样、动力障碍样和原发性NUD。39例(24%)患者正在接受H2受体拮抗剂治疗。总体而言,每日症状的强度较低,除食管炎患者的烧心评分较高外,PUD、食管炎和NUD患者(无论是否接受治疗)之间无显著差异。反流样消化不良的NUD患者烧心症状明显多于原发性NUD组;除此之外,NUD各亚组之间无差异。腹痛、烧心及整体症状的个体每日评分的平均标准差分别为平均值的64%、97%和47%,且与治疗或诊断无关。连续两天症状水平不同的概率约为40%。只有10%的患者症状稳定,在20%的观察期内患者完全无症状。本研究中,消化不良患者的症状强度较低且变异性较高。这些因素可能是临床试验中重要的偏倚来源。

相似文献

1
The intensity and variability of symptoms in dyspepsia.消化不良症状的强度和变异性。
Scand J Prim Health Care. 1993 Mar;11(1):50-5. doi: 10.3109/02813439308994902.
2
The symptomatic effect of 1-day treatment periods with cimetidine in dyspepsia. Combined results from randomized, controlled, single-subject trials.西咪替丁一日治疗期对消化不良的症状性疗效。随机对照单受试者试验的综合结果。
Scand J Gastroenterol. 1991 Sep;26(9):974-80. doi: 10.3109/00365529108996251.
3
Use of H2-receptor antagonists in patients with dyspepsia and heartburn: a cost comparison.
Med J Aust. 1991 Jul 1;155(1):20-6. doi: 10.5694/j.1326-5377.1991.tb116372.x.
4
Self-administered symptom questionnaires in patients with dyspepsia and their yield in discriminating between endoscopic diagnoses.消化不良患者的自我管理症状问卷及其在内镜诊断鉴别中的诊断价值
Dig Dis. 2002;20(2):191-8. doi: 10.1159/000067482.
5
Are clinical patterns of dyspepsia a valid guideline for appropriate use of endoscopy? A report on 2253 dyspeptic patients.消化不良的临床模式是合理使用内镜检查的有效指南吗?一项关于2253例消化不良患者的报告。
Am J Gastroenterol. 1993 Jul;88(7):1011-5.
6
Association between clinical manifestations of complicated and uncomplicated peptic ulcer and visceral sensory dysfunction.复杂性与非复杂性消化性溃疡的临床表现与内脏感觉功能障碍之间的关联
J Gastroenterol Hepatol. 2010 Jun;25(6):1162-9. doi: 10.1111/j.1440-1746.2010.06269.x.
7
Molecular hydrogen in human breath: a new strategy for selectively diagnosing peptic ulcer disease, non-ulcerous dyspepsia and Helicobacter pylori infection.人体呼出气体中的分子氢:一种选择性诊断消化性溃疡病、非溃疡性消化不良和幽门螺杆菌感染的新策略。
J Breath Res. 2016 Jul 22;10(3):036007. doi: 10.1088/1752-7155/10/3/036007.
8
The Glasgow Dyspepsia Severity Score--a tool for the global measurement of dyspepsia.格拉斯哥消化不良严重程度评分——一种用于全球消化不良测量的工具。
Eur J Gastroenterol Hepatol. 1996 Oct;8(10):967-71. doi: 10.1097/00042737-199610000-00006.
9
Peptic ulcer and non-ulcer dyspepsia--a disease and a disorder.消化性溃疡与非溃疡性消化不良——一种疾病和一种功能紊乱状态。
Scand J Prim Health Care. 1988 Nov;6(4):239-43. doi: 10.3109/02813438809009324.
10
Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.幽门螺杆菌感染二线治疗的根除率:非溃疡性消化不良与消化性溃疡疾病的比较。
Hepatogastroenterology. 2007 Jun;54(76):1293-6.

引用本文的文献

1
Doubtful outcome of the validation of the Rome II questionnaire: validation of a symptom based diagnostic tool.罗马 II 问卷验证结果存疑:基于症状的诊断工具验证。
Health Qual Life Outcomes. 2009 Dec 29;7:106. doi: 10.1186/1477-7525-7-106.
2
Management of functional dyspepsia: Unsolved problems and new perspectives.功能性消化不良的管理:未解决的问题与新视角
World J Gastroenterol. 2005 Nov 14;11(42):6577-81. doi: 10.3748/wjg.v11.i42.6577.
3
A 9 year prospective cohort study of endoscoped patients with upper gastrointestinal symptoms.
一项针对有上消化道症状的内镜检查患者的9年前瞻性队列研究。
Eur J Epidemiol. 2005;20(7):619-27. doi: 10.1007/s10654-005-4304-5.
4
Natural history of dyspepsia.消化不良的自然病史。
Gut. 2002 May;50 Suppl 4(Suppl 4):iv2-9. doi: 10.1136/gut.50.suppl_4.iv2.
5
An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.幽门螺杆菌时代未做检查的消化不良管理的循证方法。加拿大消化不良工作组。
CMAJ. 2000 Jun 13;162(12 Suppl):S3-23.